← boothcheck

HUM vs OSCR stock comparison

HUMANA INC vs Oscar Health, Inc., two Managed Care stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.

Humana carries 0.75 turns of debt against equity and a 1.77 current ratio, the balance sheet of an incumbent absorbing a bad Medicare cycle; Oscar carries 0.26 turns, the light frame of a startup that cannot afford weight. Neither earns: Humana's 0.8% net margin and Oscar's negative 0.3% leave both multiple-less this year. The operating lines split oddly, Oscar's 15.2% against Humana's 4.4%, individual-market pricing against MA benefit-cost pressure, but Humana's line survives to a small profit and Oscar's does not. The 28.5% and 2.8% free-cash figures are float. An incumbent priced for cyclical repair faces a challenger priced for structural arrival; the balance sheets say both can wait a while.

Comparison updated 2026-07-10.

HUM vs OSCR: the numbers

MetricHUMOSCR
Price$383.89$29.79
Market cap$46.3B$9.8B
SectorManaged CareManaged Care
StageGrowthGrowth
P/B2.485.89
P/S0.340.74
EV/EBITDA17.3309.2
Revenue growth+13.9%+30.5%
Operating margin4.4%15.2%
Net margin0.8%-0.3%
Return on equity6.1%-2.4%
Return on assets2.0%-0.4%
Return on invested capital5.9%0.5%
FCF yield2.8%28.5%
Dividend yield0.9%
Debt / equity0.750.26
Current ratio1.771.09
Altman Z (solvency)4.472.14
Piotroski F (quality)8 / 98 / 9
Full HUM report → Full OSCR report →
Get boothcheck's read on HUM and OSCR, and what their prices are betting on, in your inbox. No hype, no spam.
Free. Informational only, not investment advice. Unsubscribe anytime.

Compare any two stocks

vs

The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.